FI894520A - Förfarande för framställning av terapeutiskt aktiva 8-aminosubstituerade-7,8-dihydro-6,6-dimetyl-6H-pyrano/2,3-f/benso-2,1,3-oxadiazoler - Google Patents

Förfarande för framställning av terapeutiskt aktiva 8-aminosubstituerade-7,8-dihydro-6,6-dimetyl-6H-pyrano/2,3-f/benso-2,1,3-oxadiazoler Download PDF

Info

Publication number
FI894520A
FI894520A FI894520A FI894520A FI894520A FI 894520 A FI894520 A FI 894520A FI 894520 A FI894520 A FI 894520A FI 894520 A FI894520 A FI 894520A FI 894520 A FI894520 A FI 894520A
Authority
FI
Finland
Prior art keywords
pyrano
oxadiazoles
benzo
dihydro
dimethyl
Prior art date
Application number
FI894520A
Other languages
English (en)
Finnish (fi)
Other versions
FI90240C (sv
FI90240B (sv
FI894520A0 (sv
Inventor
Seto Kiyotomo
Matsumoto Hiroo
Kamikawaji Yoshimasa
Ohrai Kazuhiko
Nakayama Koyko
Sakoda Ryozo
Masuda Yukinori
Original Assignee
Nissan Chemical Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissan Chemical Ind Ltd filed Critical Nissan Chemical Ind Ltd
Publication of FI894520A publication Critical patent/FI894520A/sv
Publication of FI894520A0 publication Critical patent/FI894520A0/sv
Application granted granted Critical
Publication of FI90240B publication Critical patent/FI90240B/sv
Publication of FI90240C publication Critical patent/FI90240C/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI894520A 1988-02-03 1989-09-25 Förfarande för framställning av terapeutiskt aktiva 8-aminosubstituerade-7,8-dihydro-6,6-dimetyl-6H-pyrano/2,3-f/benso-2,1,3-oxadiazoler FI90240C (sv)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
JP2340988 1988-02-03
JP2340988 1988-02-03
JP4845888 1988-03-01
JP4845888 1988-03-01
JP7576288 1988-03-29
JP7576288 1988-03-29
JP12758488 1988-05-25
JP12758488 1988-05-25
JP8900106 1989-02-02
PCT/JP1989/000106 WO1989007103A1 (en) 1988-02-03 1989-02-02 Pyranobenzoxadiazole derivatives

Publications (4)

Publication Number Publication Date
FI894520A true FI894520A (sv) 1989-09-25
FI894520A0 FI894520A0 (sv) 1989-09-25
FI90240B FI90240B (sv) 1993-09-30
FI90240C FI90240C (sv) 1994-01-10

Family

ID=27457958

Family Applications (1)

Application Number Title Priority Date Filing Date
FI894520A FI90240C (sv) 1988-02-03 1989-09-25 Förfarande för framställning av terapeutiskt aktiva 8-aminosubstituerade-7,8-dihydro-6,6-dimetyl-6H-pyrano/2,3-f/benso-2,1,3-oxadiazoler

Country Status (17)

Country Link
US (1) US4900752A (sv)
EP (1) EP0327127B1 (sv)
JP (1) JPH0699439B2 (sv)
KR (1) KR970009591B1 (sv)
AU (1) AU609244B2 (sv)
BG (1) BG50159A3 (sv)
BR (1) BR8905292A (sv)
CA (1) CA1331990C (sv)
DE (1) DE68900210D1 (sv)
DK (2) DK167533B1 (sv)
ES (1) ES2039292T3 (sv)
FI (1) FI90240C (sv)
GR (1) GR3002637T3 (sv)
HU (1) HU206117B (sv)
RU (1) RU2054007C1 (sv)
WO (1) WO1989007103A1 (sv)
ZA (1) ZA89860B (sv)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5097037A (en) * 1989-07-17 1992-03-17 Nissan Chemical Industries, Ltd. Process for the optical resolution of pyranobenzoxadiazole compounds
GB8924373D0 (en) * 1989-10-30 1989-12-20 Beecham Group Plc Novel compounds
DE4010097A1 (de) * 1990-03-29 1991-10-02 Basf Ag Ungesaettigte n-benzoxodiazolopyranyllactame, ihre herstellung und verwendung
JPH04342591A (ja) * 1990-07-10 1992-11-30 Nissan Chem Ind Ltd ピラノベンゾオキサジアゾール誘導体
US5164509A (en) * 1990-11-26 1992-11-17 E. R. Squibb & Sons, Inc. Benzodiazolo analogs
EP0492391A3 (en) * 1990-12-26 1993-01-20 Nissan Chemical Industries Ltd. Hair growth stimulator
CA2061179A1 (en) * 1991-02-18 1992-08-19 Ryuji Tsuzuki Oxzazinobenzazole compounds
US5352814A (en) * 1991-08-30 1994-10-04 Nissan Chemical Industries, Ltd. Asymmetric epoxidation reaction
TW384291B (en) * 1993-04-02 2000-03-11 Nissan Chemical Ind Ltd Compounds for reinforcing the contraction of cardiac muscles and reducing the rate of heart beats
AU2005223612B2 (en) * 2004-03-23 2010-06-24 Nissan Chemical Industries, Ltd. Tricyclic benzopyran compound as anti-arrhythmic agents
GB0615670D0 (en) * 2006-08-07 2006-09-13 Syngenta Participations Ag Chemical compounds
US9839920B2 (en) 2009-10-06 2017-12-12 Satorius Stedim North America Inc. Apparatus for manipulating particles using at least one chamber having an inlet and an opposed outlet

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH25238A (fr) * 1901-10-22 1903-04-30 Fredinand Rozes Jean Nouvelle chaufferette
FR1406106A (fr) * 1963-04-10 1965-07-16 Daiichi Seiyaku Co Procédé de production de composés stéroïdes du [2, 3-c]-furazane
JPS5912738Y2 (ja) * 1979-04-20 1984-04-17 オリンパス光学工業株式会社 電源接続装置
EP0028064B1 (en) * 1979-09-28 1983-07-20 Beecham Group Plc Chromanol derivatives, a process for their preparation and a pharmaceutical composition comprising them
DE3064285D1 (en) * 1979-09-28 1983-08-25 Beecham Group Plc Chromanol derivatives, a process for their preparation and a pharmaceutical composition comprising them
EP0033612B1 (en) * 1980-02-02 1984-04-11 Beecham Group Plc Pyrano derivatives, a process for their preparation and antihypertensive compositions containing them
ZM7682A1 (en) * 1981-09-25 1983-05-23 Beecham Group Plc Active compounds

Also Published As

Publication number Publication date
BR8905292A (pt) 1990-08-21
DE68900210D1 (de) 1991-09-26
US4900752A (en) 1990-02-13
AU2963389A (en) 1989-08-03
FI90240C (sv) 1994-01-10
EP0327127A1 (en) 1989-08-09
GR3002637T3 (en) 1993-01-25
AU609244B2 (en) 1991-04-26
ZA89860B (en) 1989-10-25
EP0327127B1 (en) 1991-08-21
BG50159A3 (en) 1992-05-15
DK169924B1 (da) 1995-04-03
JPH0699439B2 (ja) 1994-12-07
ES2039292T3 (es) 1993-09-16
CA1331990C (en) 1994-09-13
KR900700487A (ko) 1990-08-13
RU2054007C1 (ru) 1996-02-10
HUT56373A (en) 1991-08-28
DK1693D0 (da) 1993-01-07
DK167533B1 (da) 1993-11-15
WO1989007103A1 (en) 1989-08-10
FI90240B (sv) 1993-09-30
DK1693A (da) 1993-01-07
KR970009591B1 (ko) 1997-06-14
FI894520A0 (sv) 1989-09-25
DK486089D0 (da) 1989-10-03
JPH0249788A (ja) 1990-02-20
HU891051D0 (en) 1990-03-28
DK486089A (da) 1989-12-01
HU206117B (en) 1992-08-28

Similar Documents

Publication Publication Date Title
FI96861C (sv) Förfarande för framställning av terapeutiskt aktiva substituerade indolylpyrrolderivat
FI890282A0 (sv) Förfarande för framställning av terapeutiskt användbara 23,24-didehydro-25-hydroxikalciferolderivat
FI891492A0 (sv) Förfarande för framställning av terapeutiskt aktiva bis-(hydroximetyl)cyklobutylpuriner och -pyrimidiner
NO179584C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-acylaminotiazoler
KR910700249A (ko) 신규 치료학적 활성 화합물 및 그의 제조 방법
FI873205A (sv) Förfarande för framställning av terapeutiskt aktiva bensimidazolderivat
NO178619C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive di-t-butylfenoler
NO175978C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive bis-aza-bicykliske forbindelser
NO174467C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive kromanderivater
NO176275C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive pyridazinonderivater
FI895417A0 (sv) Förfarande för framställning av nya terapeutiskt användbara 2'-halometylidennukleosider
FI872517A0 (sv) Förfarande för framställning av terapeutiskt användbara makrolidföreningar
NO173334C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive alkylaminoalkylenderivater 2H-1-benzopyraner
FI894520A (sv) Förfarande för framställning av terapeutiskt aktiva 8-aminosubstituerade-7,8-dihydro-6,6-dimetyl-6H-pyrano/2,3-f/benso-2,1,3-oxadiazoler
NO174959C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive N-aminobutyl-N-fenyl-arylamidderivater
FI93444B (sv) Förfarande för framställning av terapeutiskt aktiva dihydropyridinföreningar
FI883672A (sv) Förfarande för framställning av terapeutiskt användbara aminoalkoxifenylderivat
NO173784C (no) Anaslogifremgangsmaate for fremstilling av terapeutisk aktive tieno-tri-azolo-diazepinderivater
NO174391C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive kromanderivater
FI884660A0 (sv) Förfarande för framställning av terapeutiskt aktiva 2,2-dimetylkromenderivat
FI893003A (sv) Förfarande för framställning av terapeutiskt användbara neplanocinderivat
FI892684A (sv) Förfarande för framställning av terapeutiskt aktiva 4-oxo-imidazo/1,5-a/kinoxalinderivat
NO174422C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive kromanderivater
NO174200C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-imino-6-polyfluoralkoksybenzotiazol-forbindelser
FI903077A0 (sv) Förfarande för framställning av terapeutiskt aktiva R(-)-3-kinuklidinolderivat

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed

Owner name: NISSAN CHEMICAL INDUSTRIES, LTD.